Xilian Xu | Nanotechnology and Materials Science | Research Excellence Award

Published on by New Scientists

Dr. Xilian Xu | Nanotechnology and Materials Science | Research Excellence Award

Lecturer | Zhejiang University of Science and Technology | China

Dr. Xilian Xu is an accomplished researcher with a strong scholarly impact, evidenced by 2,289 Scopus citations, 38 peer-reviewed publications, and an h-index of 25. His research portfolio centers on high-quality journal articles, conference contributions, and scholarly outputs that advance fundamental and applied science. Dr. Xilian Xu’s work demonstrates consistent contributions to innovative research themes, addressing complex scientific questions through rigorous experimental design and analytical methodologies. He has actively contributed to competitive research projects and funded programs, supporting translational and interdisciplinary research outcomes. His scholarly activities include research findings with measurable academic and societal impact, reflected in citation performance and journal visibility. Dr. Xilian Xu has also contributed to innovation-driven R&D activities, strengthening knowledge transfer and applied research potential. In addition, he has provided professional service as a peer reviewer and editorial contributor, supporting research quality and integrity within the scientific community. His research achievements and recognitions underscore sustained excellence and influence in his field.

Research Metrics (Scopus)

2500

2000

1500

1000

500

0

Citations
2,289

Documents
38

h-index
25

Citations

Documents

h-index

View Scopus Profile

Featured Publications

Peijia Bai | Nanotechnology and Materials Science | Best Researcher Award

Published on by New Scientists

Dr. Peijia Bai | Nanotechnology and Materials Science | Best Researcher Award

Assistant Research Fellow | Beihang University | China

Dr. Peijia Bai is an emerging materials scientist whose research significantly advances high-efficiency thermal management, electrothermal conversion, and radiative cooling technologies. His work centers on electrocaloric materials and devices, ultrafast-response phase-change materials (PCMs), thermal system design, and protective color radiative-cooling coatings. With a strong focus on bridging fundamental materials science with practical applications, he has contributed to establishing next-generation energy-efficient cooling strategies and improving heat-dissipation performance for electronic and aerospace systems. Dr. Peijia Bai has published more than 30 peer-reviewed journal articles across leading platforms including Advanced Materials, Nature Communications, Science, and Joule, with over 812 Scopus citations, 24 documents and an h-index of 14. His publications include more than 10 papers as first or corresponding author, highlighting his prominent role in driving independent innovations. He has also contributed to one research monograph and authored multiple high-impact conference papers that extend his work to global scientific communities. A major contribution of his research is the development of a standardized electrothermal-effect measurement protocol, which has been widely adopted by both academia and industry. This standardized method has been cited extensively in top-tier journals and is now considered an important benchmark for evaluating electrothermal device performance. His work has also yielded seven patented technologies covering thermal-functional materials and device architectures, demonstrating strong translational potential. Dr. Peijia Bai has led and contributed to multiple funded research projects related to thermal management materials, advanced cooling devices, and energy-conversion technologies. His innovations have earned him the prestigious SAMPE International Award and recognition within professional societies such as the Zhejiang Society for Materials Progress. He also serves on the young editorial boards of cScience and Renewable and Sustainable Energy, reflecting his growing influence in the field. Dr. Peijia Bai’s research continues to advance innovative thermal strategies, contributing impactful solutions for sustainable energy technologies, aerospace materials, and advanced electronic systems.

Profiles: Scopus | ORCID | ResearchGate

Featured Publications

1. Bai, P., Yang, Q., & Yu, S. (2025). Electrocaloric refrigeration utilizing lead-free multilayer ceramics with high heat transfer efficiency. Applied Thermal Engineering. https://doi.org/10.1016/j.applthermaleng.2025.128927

2. Bai, P., Yang, Q., & Yu, S. (2025). Integration of efficient photothermal and flexible solid-solid PCM for personal thermoregulation in cold environments. iScience. https://doi.org/10.1016/j.isci.2025.114032

3. Wang, G., Bai, P., Yuan, S., Bo, Y., Zhang, D., & Ma, R. (2025). Flexible electrocaloric polymer stack driven by one AA battery for highly efficient personalized thermoregulation. Nano Letters, 25. https://doi.org/10.1021/acs.nanolett.5c03730

4. Wang, G., Bai, P., Yuan, S., Bo, Y., Zhou, Z., Zhang, D., & Ma, R. (2025). Highly efficient cooling via synergistic electro‐thermal phase changes. Advanced Materials. https://doi.org/10.1002/adma.202506006

5. Ma, W., Liu, X., Yang, T., Wang, J., Qiu, Z., Cai, Z., Bai, P., Ji, X., & Huang, Y. (2025). Strong magnetic–dielectric synergistic gradient metamaterials for boosting superior multispectral ultra‐broadband absorption with low‐frequency compatibility. Advanced Functional Materials. https://doi.org/10.1002/adfm.202314046

Sofia Teixeira | Nanotechnology and Materials Science | Editorial Board Member

Published on by New Scientists

Dr. Sofia Teixeira | Nanotechnology and Materials Science | Editorial Board Member

Senior Researcher | Tyndall National Institute | Ireland

Dr. Sofia Teixeira is a nanotechnology-focused researcher whose work bridges advanced materials science, biomedical engineering, and micro/nanofabrication. Her research background centers on the design and development of nanoscale sensing platforms capable of detecting disease-associated biomolecules with high sensitivity and selectivity. Trained in nanotechnology and electrochemical sensing, she has contributed to innovations in biomedical devices, electronic materials, and diagnostic interfaces, with a strong emphasis on translational applications that support early disease detection. Her research outputs include peer-reviewed journal publications, conference communications, and technology-driven studies exploring functional nanomaterials, biomarker recognition systems, and bio-electronic interfaces. With 89 citations, 4 research documents, and an h-index of 3, her contributions reflect an emerging yet impactful presence in the fields of nanosensors, biomaterials, and applied biotechnology. She has also advanced fabrication protocols using micro- and nanofabrication techniques, contributing to improved device performance, reproducibility, and real-world applicability. Dr. Sofia Teixeira has been involved in multidisciplinary R&D efforts linked to biomedical diagnostics, electrochemical sensor optimization, and nanostructured material design. Her work frequently integrates chemical engineering, electrochemistry, and medical biotechnology, positioning her research within critical domains such as point-of-care diagnostics, biosensing technologies, and health-related nanotechnology. She has participated in collaborative research initiatives and has contributed to the scientific community through reviewer service and research dissemination activities. Her innovations in nanoscale detection platforms and biomedical materials continue to support the advancement of next-generation diagnostic technologies and applied sensor research.

Profiles: Scopus | ORCID | Google Scholar | ResearchGate | Loop 

Featured Publications

  • Azzopardi, E., Lloyd, C., Teixeira, S. R., Conlan, R. S., & Whitaker, I. S. (2016). Clinical applications of amylase: Novel perspectives. Surgery, 160(1), 26–37.

  • Teixeira, S., Burwell, G., Castaing, A., Gonzalez, D., Conlan, R. S., & Guy, O. J. (2014). Epitaxial graphene immunosensor for human chorionic gonadotropin. Sensors and Actuators B: Chemical, 190, 723–729.

  • Teixeira, S., & Sampaio, P. (2013). Food safety management system implementation and certification: Survey results. Total Quality Management & Business Excellence, 24(3–4), 275–293.

  • Teixeira, S., Conlan, R. S., Guy, O. J., & Sales, M. G. F. (2014). Label-free human chorionic gonadotropin detection at picogram levels using oriented antibodies bound to graphene screen-printed electrodes. Journal of Materials Chemistry B, 2(13), 1852–1865.

  • Berbel-Filho, W. M., Berry, N., Rodríguez-Barreto, D., Teixeira, S., … (2020). Environmental enrichment induces intergenerational behavioural and epigenetic effects on fish. Molecular Ecology.

 

Brahma Singh | Nanotechnology and Materials Science | Best Researcher Award

Published on by New Scientists

Dr. Brahma Singh | Nanotechnology and Materials Science | Best Researcher Award

Senior Principal Scientist | CSIR – National Botanical Research Institute (NBRI) | India

Dr. Brahma Singh is a highly cited researcher in herbal nanobiotechnology, phytochemistry, microbial metabolomics, and natural-product–based therapeutics. With Scopus 6,632+ citations, 514+ cumulative journal impact factor, h-index 41, and 88+ Scopus-indexed documents, his work significantly advances plant-derived bioactives, nanodelivery systems, and biomedical applications. His research focuses on the bio-prospection of phytochemicals, metabolomics of plants and microbes, and the development of nano-enabled herbal formulations to enhance bioavailability, anti-inflammatory potential, antimicrobial efficacy, and immunomodulatory responses. He has pioneered several innovations targeting quorum sensing, biofilm inhibition, microbial virulence, oxidative stress, cancer therapeutics, and nanobiomaterial engineering. Dr. Brahma Singh has authored numerous high-impact publications in leading journals such as Biotechnology Advances, Trends in Biotechnology, Advanced Functional Materials, ACS Applied Bio Materials, Food Chemistry, Scientific Reports, Cancer and Metastasis Reviews, and Journal of Ethnopharmacology. Many of his articles address critical biomedical challenges, including COVID-19 inflammatory pathways, diabetic wound healing, gut microbiota modulation, and lichen- or plant-derived anticancer compounds. His research findings have been widely recognized for introducing bio-inspired nanoparticles, novel glycobiotechnology approaches, and sustainable valorization of agricultural waste. He holds 13 patents spanning herbal formulations, antimicrobial gels, nanocompositions, bioavailable curcumin technologies, dental care products, wound-healing biomaterials, and nutraceutical innovations. Dr. Brahma Singh has also developed 16 herbal technologies, including anti-fungal gels, polyherbal toothpaste, antioxidant supplements, advanced sanitizers, nanocoatings, anti-acne gels, and herbal hydrogel therapies-15 of which have been successfully transferred to industry.As an active contributor to the scientific community, he has published one edited book, nine book chapters, and serves on editorial boards of reputed journals including Scientific Reports, PLoS ONE, Frontiers in Fungal Biology, and others. His research excellence has been recognized through major scientific awards and fellowships, cementing his leadership in natural product biotechnology, herbal nanomedicine, and translational phytopharmaceutical R&D.

Profiles: Scopus | ResearchGate | Loop

Featured Publications

1. Gupta, S. C., Prateeksha, P., Tripathi, T., Sidhu, O. P., & Singh, B. N. (2025). Assessment of volatile compounds variability among two Commiphora species using gas chromatography coupled with chemometric analysis and their biological activities. Journal of Essential Oil Research. (Accepted). https://doi.org/

2. Singh, B. N., Tabatabaei, M., Pandit, A., Elling, L., & Gupta, V. K. (2024). Emerging advances in glycoengineering of carbohydrates/glycans and their industrial applications. Biotechnology Advances, 72, 108324. https://doi.org/

3. Sharma, V. K., Prateeksha, P., Singh, S. P., Rao, C. V., & Singh, B. N. (2023). Nyctanthes arbor-tristis bioactive extract ameliorates LPS-induced inflammation through the inhibition of NF-κB signalling pathway. Journal of Ethnopharmacology, 320, 117382. https://doi.org/

4. Gupta, A., Singh, G. D., Gautam, A., Tripathi, T., Taneja, A. K., Singh, B. N., Roy, R., Sidhu, O. P., Panda, S. K., & Bhatt, A. (2023). Unraveling compositional study, chemometric analysis, and cell-based antioxidant potential of selective high nutraceutical value amaranth cultivars using a GC–MS and NMR-based metabolomics approach. ACS Omega, 8(50). https://doi.org/

5. Jadaun, V., Prateeksha, P., Nailwal, T., & Singh, B. N. (2023). Antioxidant activity and simultaneous estimation of four polyphenolics in different parts of Carica papaya L. by a validated high-performance thin-layer chromatography method. JPC – Journal of Planar Chromatography – Modern TLC, 1–11. https://doi.org/

Iman Akbarzadeh | Nanotechnology | Young Scientist Award

Published on by New Scientists

Mr. Iman Akbarzadeh | Nanotechnology | Young Scientist Award

Iman Akbarzadeh at School of Life Sciences, Faculty of Science, University of Technology Sydney, NSW, Australia.

Mr. Iman Akbarzadeh is an emerging researcher in the field of biomedical science, currently pursuing his Ph.D. at the University of Technology Sydney. His academic background in chemical engineering and biotechnology underpins his multidisciplinary approach to tackling major biomedical challenges. Mr. Akbarzadeh has contributed significantly to cutting-edge research in nanotechnology-based drug delivery, with a strong emphasis on preeclampsia treatment and cancer therapy. He has held research positions at several prestigious institutions in Iran, including the Research Institute for Gastroenterology & Liver Diseases, the Pasteur Institute, and Sharif University of Technology. His work has culminated in multiple high-impact publications in journals such as Coordination Chemistry Reviews and Biomaterials Advances. Beyond publishing, he actively contributes to the scientific community as a peer reviewer for top-tier journals including Pharmaceutics and the International Journal of Biological Macromolecules. With a robust skill set ranging from nanoparticle synthesis to advanced analytical techniques and a growing list of academic accolades, Mr. Akbarzadeh is poised to make impactful contributions to translational medicine and nanotherapeutics.

Publication Profile

Scopus

Educational Details

  • 2024 – Present: Ph.D. in Biomedical Science, University of Technology Sydney, Australia
    Thesis Topic: Developing Novel Strategies to Monitor and Treat Preeclampsia Using Nanotechnology Approaches.
  • 2016 – 2019: M.Sc. in Chemical Engineering – Biotechnology, Sharif University of Technology, Iran
    Thesis Topic: Niosomal Delivery of Simvastatin to MDA-MB-231 Cancer Cells.
  • 2012 – 2016: B.Sc. in Chemical Engineering, Ferdowsi University of Mashhad, Iran

Professional Experience

  • 2020 – 2024: Researcher, Research Institute for Gastroenterology & Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • 2017 – 2023: Researcher, Nanobiotechnology Department, Pasteur Institute, Tehran, Iran
  • 2019 – 2023: Researcher, Nanotechnology and Drug Delivery Laboratory, Sharif University of Technology, Tehran, Iran
    Mr. Akbarzadeh has played a vital role in executing projects related to drug delivery, antimicrobial therapies, and nanoparticle engineering. These positions allowed him to gain practical experience in multidisciplinary research teams focused on translational outcomes.

Research Interest

Mr. Akbarzadeh’s research interests include:

  • Drug and Gene Delivery
  • Preeclampsia and Pregnancy-related Complications
  • Cancer Research and Targeted Therapy
  • Tissue Engineering and Regenerative Medicine
  • 3D Bioprinting for Biomedical Applications
  • Wound Healing and Biomaterials
  • Microfluidics for Drug Screening
  • Extracellular Vesicles (EVs) and Intercellular Communication

Research Skills

Mr. Akbarzadeh possesses a wide range of technical and analytical skills, including:

  • Cell Culture and Assays: Cell culture, MTT assay, flow cytometry
  • Microbiology: Biofilm test, MIC-MBS assay, disk diffusion, time-kill assay
  • Biochemistry: BCA assay, ELISA
  • Analytical Methods: HPLC, UV-Vis, DLS, TEM, SEM, FTIR, XRD, DSC
  • Nanoparticle Synthesis: Lipid, metal, mesoporous silica, and polymeric nanoparticles
  • Software Proficiency: Microsoft Office, GraphPad, FIJI, SPSS, Design-Expert, Photoshop, MATLAB, BioRender, OriginPro

Awards and Honors

  • Recipient of the International Research Award on New Science Inventions in the “Best Research Award” category, 2021
  • Ranked 17th out of ~10,000 in Iran’s nationwide Master’s entrance exam, 2017
  • Ranked in the top 3% out of ~300,000 in Iran’s nationwide Bachelor’s entrance exam, 2012
    These distinctions highlight Mr. Akbarzadeh’s academic excellence and his recognition as a leading talent in his field.

Author Metrics

  • Total Publications: 54

  • Total Citations: 2,171

  • h-index: 21

  • i10-index: 35

Top Noted Publication

  1. Azari Torbat, N., Akbarzadeh, I., Rezaei, N., Moghaddam, Z., Bazzazan, S., Mostafavi, E.
    “Curcumin-Incorporated Biomaterials: In silico and in vitro evaluation of biological potentials.”
    Coordination Chemistry Reviews, 2023.
    Impact Factor (IF): 20.3
    Note: I. Akbarzadeh and N. Azari Torbat contributed equally to this work.

  1. Akbarzadeh, I., Rezaei, N., Bazzazan, S., Naderi Mezajin, M., Mansouri, A., Karbalaeiheidar, H., Ashkezari, S., Salehi Moghaddam, Z., Asghari Lalami, Z., Mostafavi, E.
    “In Silico and In Vitro Studies of GENT-EDTA Encapsulated Niosomes: A Novel Approach to Enhance the Antibacterial Activity and Biofilm Inhibition in Drug-Resistant Klebsiella pneumoniae.”
    Biomaterials Advances, 2023.
    Impact Factor (IF): 5.5

  1. Dastneshan, A., Rahiminezhad, S., Naderi Mezajin, M., Nouri, H., Akbarzadeh, I., Jahanbakhshi, M., Abdihaji, M., Qahremani, R., Asghari Lalami, Z., Heydari, H., Noorbazargan, H., Mostafavi, E.
    “In Vitro, and In Vivo, Studies of Cefazolin Encapsulated UiO-66-NH₂: A New Approach for Enhanced Antibacterial Activity and Biofilm Inhibition in Drug-Resistant Staphylococcus aureus.”
    Chemical Engineering Journal, 2023.
    Impact Factor (IF): 13.4

  1. Mansoori-Kermani, A., Khalighi, S., Akbarzadeh, I., Jahed, V., Motasadizadeh, H., Ranjbar Niavol, F., Mahdieh, A., Abdinezhad, M., Rahbariasr, N., Hosseini, M., Ahmadkhani, N., Panahi, B., Fatahi, Y., Batiha, G.E.S., Mozafari, M., Mostafavi, E.
    “Engineered Hyaluronic Acid-Decorated Niosomal Nanoparticles for Controlled and Targeted Delivery of Epirubicin to Treat Breast Cancer.”
    Materials Today Bio, 2022.
    Impact Factor (IF): 8.7

  1. Akbarzadeh, I., Saremi Poor, A., Khodarahmi, M., Abdihaji, M., Moammeri, A., Jafari, S., Salehi Moghaddam, Z., Seif, M., Moghtaderi, M., Asghari Lalami, Z., Heydari, M., Adelnia, H., Farasati Far, B.
    “Gingerol/Letrozole-Loaded Mesoporous Silica Nanoparticles for Breast Cancer Therapy: In-Silico and In-Vitro Studies.”
    Microporous and Mesoporous Materials, 2022.
    Impact Factor (IF): 4.8

  1. Ghafelehbashi, R., Akbarzadeh, I., Tavakkoli Yaraki, M., Lajevardi, A., Fatemizadeh, M., Heidarpoor Saremi, L.
    “Preparation, Physicochemical Properties, In Vitro Evaluation and Release Behavior of Cephalexin-Loaded Niosomes.”
    International Journal of Pharmaceutics, 2019.
    Impact Factor (IF): 5.3

Conclusion

Mr. Iman Akbarzadeh is a dedicated and accomplished biomedical researcher with a unique interdisciplinary foundation in chemical engineering and nanobiotechnology. He is currently expanding the frontiers of knowledge in maternal-fetal health through his doctoral research in preeclampsia. With experience in leading research institutes, a portfolio of high-impact publications, and an active role in scientific peer review, Mr. Akbarzadeh demonstrates strong potential for future leadership in biomedical innovation. His technical competencies and scholarly contributions are instrumental to advancing novel diagnostic and therapeutic strategies in medicine.